Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion. - Wikidata - awgldk - TriplyDB

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

http://www.wikidata.org/entity/Q44605515

about

Leukocyte tyrosine kinase functions in pigment cell development Anaplastic lymphoma kinase: signalling in development and disease p130Cas mediates the transforming properties of the anaplastic lymphoma kinase Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation The role of the ALK receptor in cancer biology Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs Emerging importance of ALK in neuroblastoma Insulin/IGF-regulated size scaling of neuroendocrine cells expressing the bHLH transcription factor Dimmed in Drosophila The Rap1 guanine nucleotide exchange factor C3G is required for preservation of larval muscle integrity in Drosophila melanogaster FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas Expression-guided in silico evaluation of candidate cis regulatory codes for Drosophila muscle founder cells Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells Identification of receptor-tyrosine-kinase-signaling target genes reveals receptor-specific activities and pathway branchpoints during Drosophila development Genetic control of fusion pore expansion in the epidermis of Caenorhabditis elegans.The FGF8-related signals Pyramus and Thisbe promote pathfinding, substrate adhesion, and survival of migrating longitudinal gut muscle founder cells.Hand is a direct target of the forkhead transcription factor Biniou during Drosophila visceral mesoderm differentiation.Characterisation of the role of Vrp1 in cell fusion during the development of visceral muscle of Drosophila melanogaster An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanol.The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.HLH54F is required for the specification and migration of longitudinal gut muscle founders from the caudal mesoderm of Drosophila The Drosophila midkine/pleiotrophin homologues Miple1 and Miple2 affect adult lifespan but are dispensable for alk signaling during embryonic gut formation.Anaplastic lymphoma kinase is required for neurogenesis in the developing central nervous system of zebrafish.Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus.Distinct genetic programs guide Drosophila circular and longitudinal visceral myoblast fusion.Glycosylated synaptomatrix regulation of trans-synaptic signaling.Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.Pathobiology of ALK+ anaplastic large-cell lymphoma.What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?The Zic family homologue Odd-paired regulates Alk expression in Drosophila C. elegans anaplastic lymphoma kinase ortholog SCD-2 controls dauer formation by modulating TGF-beta signaling Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.Org-1 is required for the diversification of circular visceral muscle founder cells and normal midgut morphogenesis.Receptor tyrosine kinases in Drosophila development.Targeting ALK in neuroblastoma--preclinical and clinical advancements.Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.The midkine family of growth factors: diverse roles in nervous system formation and maintenance.Treating ALK-positive lung cancer--early successes and future challenges.Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer.

P2860

38d6124e3603eeb592100039317e49982bc3a7de f244008111b88d8dbcce5054da87a7c3c1c850c6

P248

Q21092480-ECD2865D-649B-4F99-B0D8-CDF1C3C4ADAE Q24312329-31DD6DC2-059B-4AEC-A96C-61D9D8A640D6 Q24315788-C8815E43-EEBF-4EBA-A3B7-C74739CF17AC Q24336817-C6A84F16-7C82-485A-A454-149B91A6B5D4 Q26738384-9524613E-C1B7-4B21-9962-4F931B6104CB Q26769659-77DDF1B8-996E-4B3C-A238-6F913B0018B1 Q26858819-0D010A79-AD24-4C2A-884C-BCF1F700C599 Q27318076-5D3BD239-AA9E-4293-A7DE-A79EACDA07B3 Q27334109-17933B28-DBD8-4625-B062-F2E0CFDCB270 Q28118071-81DD89C9-E9F2-456A-AA77-EF7C2932983A Q28300128-BD08A88C-087D-49BB-8015-D52846B9BC1A Q28469232-6E79CDBC-7672-43D8-85EB-B2BCC4572A05 Q28571575-F0BE0E0B-2993-4E16-A5A3-FA002A17421E Q28754824-3137B536-5C09-466B-96DB-3D901F4FADAC Q30479203-D3652BC5-9796-4DC9-8160-DFF952CA76C4 Q30537210-D3088E42-F5C0-4115-ACAB-A0B3E35D15C1 Q33285058-520DA501-EAC8-434F-96C4-B5288E10B733 Q33654740-08D976D9-A827-4252-84B1-6245A6DB734C Q33974947-11794221-CD80-4AC6-AEF9-FECF60B3CDB9 Q34031191-771A8614-91CB-4B31-830B-740D14A1E9DF Q34080645-985539A1-8952-46D9-8D99-B90C81AD3076 Q34473183-AFAD9C77-D4EB-4959-9213-904E0F2CDF12 Q34718402-34203FF4-CBF1-4031-B7DE-5BAAA586E432 Q34869224-6897CF70-7C32-4D4A-8241-3F2EBCFB2301 Q35202577-AF421356-4646-47F0-A619-5748A96CBF14 Q35618921-568B5219-4B31-4F40-8152-72C432A5CE29 Q35832009-714071B5-2403-4AB5-9F52-94A9B53AEFE3 Q36007756-238A7E46-410D-46D7-9407-0D9E307C49F8 Q36132014-DB52A986-3D65-4805-B018-388C3A222C03 Q36331752-4F5409C2-A8B1-4A39-9A4C-E0E7FAA4117A Q36372176-24C3C900-A8A0-4A21-BC48-BB6DB90DBBCD Q36398134-E5D6C86A-6787-4043-AC77-304AAE5757CC Q36698595-2102BA66-3DF7-48B6-92BD-95311EF3D98D Q36865167-DEFF1D23-AF77-4BA6-A52B-69ED69C078AA Q36933081-E66B83B7-C2B7-4F87-8817-469A9504083E Q37287441-455D9C69-8F37-4C37-AFFC-08F59F4E1A7D Q37411178-3FAD6AF4-CF99-479A-9CD1-504D9356E6CE Q37585398-1CE50ADC-9C92-4C83-93DD-9A195DA5C9B8 Q37999657-4FF21F78-5689-4915-9B78-F704E250EFEB Q38148969-A9503324-918B-40C8-8A68-3885DD0C5A73

P2860

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

http://www.wikidata.org/entity/Q44605515

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

@en

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

@nl

type

label

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

@en

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

@nl

prefLabel

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

@en

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion.

@nl

P1433

Q44605515-99B45114-2EAF-4CF6-B4D0-3F97C118E36E

P1476

Q44605515-7CA9424F-16AB-4878-91C0-57FA0FAE7169

P2093

Q44605515-5CFC9614-20BB-439D-8FCB-C47F0DAD3BDF

Q44605515-79C23CEF-5213-406B-B0F8-77D5B1A664A1

Q44605515-99697B97-9C01-4825-AF15-6BEDC4259E43

Q44605515-FC6B8B14-2995-4841-952B-906E7E5D2FF9

P2860

Q44605515-039162B4-40ED-4B2B-AA96-1A49C5CB1D11

Q44605515-18737A75-DB8E-4D89-9135-297D58D5D37E

Q44605515-32214FD5-AF26-49DE-BDDE-CA562500BDB3

Q44605515-4D9D73B8-9C0E-4C91-88E2-76F49147DC42

Q44605515-5AB65257-5424-47AD-967F-CA33740C133E

Q44605515-64705940-185E-4C52-AEC9-03DC49C369B7

Q44605515-69840404-8A65-45CA-858B-DFA1F417B442

Q44605515-70ADDEF8-C5FB-49E6-883F-B53841D40D9C

Q44605515-7E2DD5B2-58A1-4650-A045-5B6A015A7BFF

Q44605515-BECED927-25A5-4CD8-B163-CEDAB6E09119

P2888

Q44605515-0F061C23-D7CE-45D3-A460-E459CCB494AC

P304

Q44605515-815513D6-B755-4B7D-A658-7E3347D68301

P31

Q44605515-7CE89969-4A11-453F-ADC1-A0B52BBA0136

P356

Q44605515-8BD52444-6592-424D-B61B-6B1E7B09F77C

P407

Q44605515-88CA6844-E1DB-4687-8D00-3744D1219FA9

P433

Q44605515-4013B3ED-9729-4304-8A66-028F3ED775C8

P478

Q44605515-E6FC71A4-31EC-4C3E-AA2D-1A87130BF051

P50

Q44605515-211A59DD-18F3-4253-A1EC-867A61249897

Q44605515-661F1D28-43DE-4B65-98BF-44E39A915C16

Q44605515-6C8A06F0-6DA1-4349-94F1-36B95899A87B

P577

Q44605515-DDB2E027-4899-455F-AA1C-96ECE1F307A8

P6179

Q44605515-02D86E7A-6007-4B61-BB96-EB2EBBFB842A

P698

Q44605515-537F0430-885F-4676-B54B-A3916289CF55

P356

P1433

P1476

Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion

@en

P2093

Camilla Englund

http://www.w3.org/2001/XMLSchema#string

Caroline Grabbe

http://www.w3.org/2001/XMLSchema#string

Christina E Lorén

http://www.w3.org/2001/XMLSchema#string

Fabienne Deleuil

http://www.w3.org/2001/XMLSchema#string

P2860

PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

Identification and characterization of DAlk: a novel Drosophila melanogaster RTK which drives ERK activation in vivo

Lethal of scute, a proneural gene, participates in the specification of muscle progenitors during Drosophila embryogenesis.

Invertebrate myogenesis: looking back to the future of muscle development.

Anaplastic large cell lymphoma: pathological, molecular and clinical features.

Translocations involving anaplastic lymphoma kinase (ALK).

P2888

P304

512-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE01950

http://www.w3.org/2001/XMLSchema#string

P407

P433

6957

http://www.w3.org/2001/XMLSchema#string

P478

425

http://www.w3.org/2001/XMLSchema#string

P50

Gaurav K. Varshney

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012399690

http://www.w3.org/2001/XMLSchema#string

P698

14523447

http://www.w3.org/2001/XMLSchema#string